Activin receptor-like kinase 1 as a target for anti-angiogenesis therapy

Author： Hawinkels Lukas JAC Garcia de Vinuesa Amaya ten Dijke Peter

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.11, 2013-11, pp. : 1371-1383

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Activin Receptor-Like Kinase 1: a Novel Anti-angiogenesis Target from TGF-β Family

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 10, 2013-08 ,pp. : 1398-1406

Bentham Science Publishers

Access to resources Recommend Favorite

Peptides to Target Tumor Vasculature and Lymphatics for Improved Anti-Angiogenesis Therapy

Current Cancer Drug Targets, Vol. 16, Iss. 6, 2016-07 ,pp. : 522-535

Bentham Science Publishers

Access to resources Recommend Favorite

Thermoreversible gel for delivery of activin receptor-like kinase 5 inhibitor SB-505124 for glaucoma filtration surgery

By Sutariya Vijaykumar Miladore Nicholas Geldenhuys Werner Bhatia Deepak Wehrung Daniel Nakamura Hiroshi

Pharmaceutical Development and Technology, Vol. 18, Iss. 4, 2013-08 ,pp. : 957-962

Informa Healthcare

Access to resources Recommend Favorite

Activin Receptor-Like Kinases: Structure, Function and Clinical Implications

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 1, 2006-03 ,pp. : 45-58

Bentham Science Publishers

Access to resources Recommend Favorite

Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy

By Fan T.-P.D. Jaggar R. Bicknell R.

Trends in Pharmacological Sciences, Vol. 16, Iss. 2, 1995-02 ,pp. : 57-66

Elsevier

Access to resources Recommend Favorite